We are live on
!
Find out more
PDLI
PDL BioPharma, Inc.
PDLI
PDLI
Delisted
PDLI was delisted on the 30th of December, 2020.
233 hedge funds and large institutions have $1.18B invested in PDL BioPharma, Inc. in 2014 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 93 increasing their positions, 68 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
397% more call options, than puts
Call options by funds: $12.7M | Put options by funds: $2.55M
42% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 24
37% more repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 68
4% more funds holding
Funds holding: 224 → 233 (+9)
1% more capital invested
Capital invested by funds: $1.17B → $1.18B (+$8.69M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
233
Holders Change
+9
Holders Change %
+4.02%
% of All Funds
6.73%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
34
Increased
93
Reduced
68
Closed
24
Calls
$12.7M
Puts
$2.55M
Net Calls
+$10.1M
Net Calls Change
+$1.1M
Top Buyers
| 1 |
Schroder Investment Management Group
London,
United Kingdom
|
+$31.5M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$17.6M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.4M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$10.4M |
| 5 |
Two Sigma Investments
New York
|
+$9.96M |
Top Sellers
| 1 |
GAM
Gotham Asset Management
New York
|
-$14.4M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$8.09M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.7M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$7.65M |
| 5 |
JP Morgan Chase
New York
|
-$6.95M |
